Novel strategies and therapeutic options for the management of primary biliary cholangitis
Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease. It has a varied course of progression ranging from being completely asymptomatic to aggressive disease leading to cirrhosis and resulting in liver transplantation. In addition, symptoms can be debilitating and can have a major...
Main Authors: | Amardeep Khanna, David E. Jones |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-10-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/1756283X17728669 |
Similar Items
-
Novel therapeutic targets for primary biliary cholangitis
by: CHEN Rongbin, et al.
Published: (2017-05-01) -
Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis
by: Dong-Won Ahn
Published: (2020-05-01) -
Update on Emerging Treatment Options for Primary Biliary Cholangitis
by: Aguilar MT, et al.
Published: (2020-05-01) -
Primary biliary cholangitis
by: I. M. Iljinsky, et al.
Published: (2021-04-01) -
Rituximab for the treatment of fatigue in primary biliary cholangitis (formerly primary biliary cirrhosis): a randomised controlled trial
by: Amardeep Khanna, et al.
Published: (2018-04-01)